Dr. Matthew A. Parrish, DO is a family medicine practitioner in Tampa, FL specializing in family medicine. He graduated from Lake Erie College of Osteopathic Medicine Bradenton in 2019 and has 6 years of experience. Dr. Matthew A. Parrish, DO is affiliated with Optum, Optum Florida and OPTUMCARE FLORIDA, LLC.
Dr. Matthew A. Parrish, DO graduated from Lake Erie College of Osteopathic Medicine Bradenton in 2019. He completed residency at Larkin Hospital South Miami. He is certified by the American Board of Family Medicine and has a state license in Florida.
Medical School: Lake Erie College of Osteopathic Medicine Bradenton (2019)
Residency: Larkin Hospital South Miami
Board Certification: American Board of Family Medicine
Licensed In: Florida
Dr. Matthew A. Parrish, DO is associated with these hospitals and organizations:
Dr. Matthew A. Parrish, DO appears to accept the following insurance providers: Humana (000126174), WellCare (3383273), United (8405173), Freedom (P00054548), Careplus (1227543) and Optimum (P00046061).
According to our sources, Dr. Matthew A. Parrish, DO accepts the following insurance providers:
Dr. Matthew A. Parrish, DO has an exceptional overall rating with an average of 4.81 out of 5 stars based on 167 ratings. We collect ratings and reviews of Dr. Matthew A. Parrish, DO from all over the web to help you find the right in Tampa, FL.
These charts describe general payments received by Dr. Matthew A. Parrish, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| AstraZeneca Pharmaceuticals LP |
$79
FARXIGA $55 |
LOKELMA $24 |
|---|---|---|
| Pfizer Inc. |
$62
ABRYSVO $38 |
ZAVZPRET $23 |
| Sumitomo Pharma America, Inc. |
$17
GEMTESA $17 |
|
| Watermark Medical, Inc. |
$8
ARES HOME SLEEP TESTING DEVICE $8 |
| Food and Beverage | $166 |
|---|
Dr. Matthew Parrish's area of specialization is family medicine. Dr. Parrish attended medical school at Lake Erie College of Osteopathic Medicine. He has an open panel in Tampa, FL according to Yext.